Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
168.64B
Market cap168.64B
Price-Earnings ratio
26.60
Price-Earnings ratio26.60
Dividend yield
2.51%
Dividend yield2.51%
Average volume
12.89M
Average volume12.89M
High today
$97.14
High today$97.14
Low today
$94.87
Low today$94.87
Open price
$95.62
Open price$95.62
Volume
17.56M
Volume17.56M
52 Week high
$139.06
52 Week high$139.06
52 Week low
$93.92
52 Week low$93.92

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $96.95. The company's market cap stands at 168.64B, with a P/E ratio of 26.60 and a dividend yield of 2.5%.

On 2026-04-17, Abbott(ABT) stock moved within a range of $94.87 to $97.14. With shares now at $96.95, the stock is trading +2.2% above its intraday low and -0.2% below the session's peak.

Trading volume for Abbott(ABT) stock has reached 17.56M, versus its average volume of 12.89M.

The stock's 52-week range extends from a low of $93.92 to a high of $139.06.

The stock's 52-week range extends from a low of $93.92 to a high of $139.06.

ABT News

TipRanks 6h
Abbott Reaches Preliminary Settlement in Derivative Governance Case

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 7h
Abbott says data at AACR demonstrate advancements in Cancerguard test

Abbott (ABT) announced it will present new data at the American Association for Cancer Research Annual Meeting 2026 demonstrating continued advancements in its...

TipRanks 10h
Abbott Labs Stock Hit with Slew of Downgrades After Earnings

The stock of Abbott Laboratories (ABT) has been hit with multiple downgrades from Wall Street analysts after the company’s latest financial results. Unlock hed...

Analyst ratings

78%

of 32 ratings
Buy
78.1%
Hold
21.9%
Sell
0%

More ABT News

Benzinga 11h
Abbott Laboratories Sales Growth Outlook 'Leaves Room For Upside': Analyst

Shares of Abbott Laboratories (NYSE:ABT) rose in early trading on Friday, after tanking around 6% on Thursday following the company's first-quarter results. Th...

Abbott Laboratories Sales Growth Outlook 'Leaves Room For Upside': Analyst
Benzinga 13h
Abbott Laboratories Analysts Slash Their Forecasts After Q1 Earnings

Abbott Laboratories (NYSE:ABT) on Thursday posted upbeat first-quarter earnings but revised its 2026 earnings outlook below expectations. The global healthcare...

Abbott Laboratories Analysts Slash Their Forecasts After Q1 Earnings
Benzinga 1d
Netflix, AMD, Navitas Semiconductor, Abbott Labs, And Nio: Why These 5 Stocks Are On Investors' Radars Today

Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average up 0.2% at 48,578.72, the S&P 500 gaining nearly 0.3% to 7,041.28, and the N...

Netflix, AMD, Navitas Semiconductor, Abbott Labs, And Nio: Why These 5 Stocks Are On Investors' Radars Today
TipRanks 1d
Abbott Laboratories Bets on Devices in 2026 Call

Abbott Laboratories ((ABT)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 30% Off TipRanks Unlock hedge fund-level data and...

Nasdaq 1d
Why Abbott Laboratories Stock Tumbled on Thursday

Key Points Investors had more of an issue with guidance. The company cut its full-year forecast for adjusted profitability. 10 stocks we like better than Abb...

Why Abbott Laboratories Stock Tumbled on Thursday
Simply Wall St 1d
Is Abbott Laboratories Now Offering Value After A 20% Share Price Slide?

If you are wondering whether Abbott Laboratories at around US$101.56 is offering value or just noise, it helps to step back and look at the full picture on pric...

Is Abbott Laboratories Now Offering Value After A 20% Share Price Slide?
The Wall Street Journal 1d
Abbott Stock Falls After Results Show Pressure in Several Businesses

Abbott Laboratories shares are down about 6% after the medical devices and nutrition company gave a 2026 forecast that disappointed analysts. In its first quar...

Abbott Stock Falls After Results Show Pressure in Several Businesses

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.